People's Daily, Beijing, November 22 Lung cancer is the malignant tumor with the highest incidence rate and mortality rate in China. According to the data released by the National Cancer Center in 2022, among the 4.064 million newly diagnosed cancer patients in China, the number of lung cancer patients is 828000, and among the 2.414 million people who died from cancer, 657000 suffer from lung cancer. Whether it is new cases or deaths, lung cancer is at the forefront. To further improve the standardized diagnosis and treatment level in the field of lung cancer in China, and promote the exchange and cooperation of top experts in the field of lung cancer between China and foreign countries. Recently, the "China Anti Cancer Association (CACA) Guidelines - International Master of Lung Cancer China Tour Project" organized by the China Anti Cancer Association has kicked off. Through high-level communication between Chinese and international experts, it promotes standardized diagnosis and treatment of lung cancer, thereby improving the survival period of Chinese lung cancer patients, prolonging their lives, and bringing them high-quality survival. It is understood that this China tour will hold 5 city tours in China from November 24th to 28th, including Beijing, Shanghai, Guangzhou, Changsha, Chengdu, etc; Conducted 8 inter hospital exchanges, including Peking University Oncology Hospital, Peking University First Hospital, Jiangsu Provincial People's Hospital, Hunan Provincial Oncology Hospital, Central South University Xiangya Second Hospital, Guangdong Provincial People's Hospital, Fudan University Affiliated Huashan Hospital, and Sichuan University Huaxi Hospital. During the event, an annual summary conference on the new development of precision diagnosis and treatment for lung cancer will be held to jointly review the progress of precision diagnosis and treatment for lung cancer in 2023. Listen to the voices of renowned scholars, gather international scholars, and explore advanced experiences in lung cancer. (New News Agency)